Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of liposomal amphotericin B and amphotericin B
deoxycholate with or without flucytosine followed by fluconazole for the treatment of
cryptococcal meningitis.
Phase:
N/A
Details
Lead Sponsor:
TTY Biopharm
Treatments:
Amphotericin B Amphotericin B, deoxycholate drug combination Deoxycholic Acid Liposomal amphotericin B